"Not only have a seen an outstanding amount of improvement since the program's start but these interns really look like they are having a blast in the lab."
-Jeff Morhet, President and CEO

"The focus on microbiology and micro-testing on the CDC assay will help them develop accuracy. They will also discover the potency of their DXL625 samples."
-Tom Kindt, Ph.D., Chief Scientific Officer

"During this week, the interns tested the samples they made for purity- This was a good indication of the accuracy of their technique."
-Jur Strobos, M.D., Chief Medical Officer

"The LABapprentices are coming into the final stretch. One apprentice has broke out of the pack and is clearly in the lead; however, a victory is still possible for one of the others, but will require skill, hardwork and determination.
-Mike Russ, DXL702 Program Manager, LABapprentice Supervisor

"Today they spent time learning about a recent surpreme court decision that relates to patent licensing issues. In that context, the interns learned about what a patent is and how it is 'the currency' of our industry. Hopefully, they also learned of all directions they can take in their career which still relate to their scientific backgrounds. "
-Gil Gabo, InNexus Biotechnology VP of Operations